0.405
-0.01 (-1.82%)
| Previous Close | 0.413 |
| Open | 0.407 |
| Volume | 20,396 |
| Avg. Volume (3M) | 28,578 |
| Market Cap | 1,828,696 |
| Price / Book | 0.250 |
| 52 Weeks Range | |
| Earnings Date | 7 Aug 2025 - 11 Aug 2025 |
| Diluted EPS (TTM) | -30.60 |
| Total Debt/Equity (MRQ) | 1,855.20% |
| Current Ratio (MRQ) | 1.04 |
| Operating Cash Flow (TTM) | -7.65 M |
| Levered Free Cash Flow (TTM) | -5.58 M |
| Return on Assets (TTM) | -170.96% |
| Return on Equity (TTM) | -748.05% |
AIStockmoo Score
| Value 38% | -4.6 |
| High debt. Weak profitability. Thin short-term liquidity. Negative cash flow. info | |
| From our AI Insight report's view of expected return against risk. info | NA |
| Relative Valuation info | NA |
| Implied Growth info | NA |
| Valuation History info | NA |
| Return on Capital info | NA |
| Holdings' Value info | NA |
| Risk Premium info | NA |
| Market Valuation info | NA |
| Timing 38% | -3.6 |
| Downtrend over the past year. Far below its 52-week high. info | |
| In a downtrend: the price is below its moving averages, and they are falling. It has dropped well below them. Volume is heavier on up days. info | |
| From our AI technical analysis of the chart. info | NA |
| Candle Patterns info | NA |
| Sentiment 25% | 0.0 |
| No recent price targets, so based on how targets have been revised. info | |
| Holdings' Sentiment info | NA |
| News Mood info | NA |
| Smart Money | NA |
| Insider Activity info | NA |
| Institutional Flow info | NA |
| Market and sector conditions are poor. | |
| Market environment cautious. info | |
| Sector lagging the market. | |
| The pillars agree, so the score is strengthened. | |
| Not in score | |
| Earnings per share have gone up and down. Made a loss in recent years. info | |
| Below its medium-term trend line. info | |
| Price is low against its 52-week average. Down over 5 years. info | |
| Trend down on all three terms. Short-term momentum falling. info | |
| Price is near resistance. info | |
| Final Score | -4.36 |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Oragenics Inc. | - | - |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B | Score |
|---|---|---|---|---|---|
| OGEN | 2 M | - | - | 0.250 | -4.4 |
| CYBN | 359 M | - | - | - | 0.0 |
| NRXS | 60 M | - | - | 18.58 | -1.2 |
| CVM | 21 M | - | - | 2.22 | -3.7 |
| NHWK | 20 M | - | - | 0.260 | 0.0 |
| AEON | 10 M | - | - | - | -3.3 |
Select this tab to load the latest available analysis.
|
Oragenics, Inc., a development-stage company, engages in the research and development of antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also comprise LPT3-04, a weight loss candidate; and SMaRT Replacement Therapy, a topical treatment to prevent dental carries. It has a license agreement with Noachis Terra Inc. for licensing of certain specified patent rights and biological materials relating to the use of pre-fusion coronavirus spike proteins; and a collaboration agreement ILH Holdings, Inc. for the development and commercialization of MU1140 and related homologs. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| % Held by Insiders | 12.11% |
| % Held by Institutions | 1.02% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| 25 Llc | 30 Sep 2026 | 23,160 |
| St. Johns Investment Management Company, Llc | 30 Jun 2026 | 1,924 |
| Adkins Seale Capital Management Llc | 30 Jun 2026 | 3 |
| Ameritas Advisory Services, Llc | 30 Jun 2026 | 0 |
No data within this time range.
No data within this time range.
Technical Setup Medium
AI Technical Analysis
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |